Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01563471
Recruitment Status : Completed
First Posted : March 27, 2012
Last Update Posted : January 13, 2017
Information provided by (Responsible Party):
Novo Nordisk A/S